All Stories

  1. Testing the ability of the nonalcoholic fatty liver disease fibrosis score to predict 1-year all-cause hospital admission

    Article • Baylor University Medical Center Proceedings, January 2019, Taylor & Francis

    Sharon DeMorrow

  2. Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice

    Article • Gene Expression, August 2018, Cognizant Communication Corporation

    Sharon DeMorrow

  3. Recent advances in hepatic encephalopathy

    Article • F1000Research, September 2017, Faculty of 1000, Ltd.

    Sharon DeMorrow

  4. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation

    Article • The FASEB Journal, June 2017, Federation of American Societies For Experimental Biology (FASEB)

    Sharon DeMorrow

  5. Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/−mice

    Article • Hepatology, July 2016, Wiley

    Sharon DeMorrow

  6. Effects of bile acids on neurological function and disease

    Article • The FASEB Journal, July 2016, Federation of American Societies For Experimental Biology (FASEB)

    Sharon DeMorrow

  7. Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management

    Article • Cancer Management and Research, July 2013, Taylor & Francis

    Sharon DeMorrow